Recent studies showed that TAAs also transfer mitochondria to GBM cells via growth-associated protein 43 (GAP43)-positive tumor microtube-like structures [175], and TGFβ [176], enhancing ATP production and promoting tumor growth, aggressiveness, and therapy resistance [177,178]. This evidence concerns the gene TGFB1 and neoplasm.